These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
95 related articles for article (PubMed ID: 8831923)
21. Oxidative-modified and acetylated low-density lipoproteins differ in their effects on cholesterol synthesis and stimulate synthesis of apolipoprotein E in rat peritoneal macrophages by different mechanisms. Zhang MY; Lin RC Metabolism; 1994 Dec; 43(12):1523-30. PubMed ID: 7990706 [TBL] [Abstract][Full Text] [Related]
22. Is the atherogenicity of Lp(a) caused by its reactivity with proteoglycans? Kostner GM; Bihari-Varga M Eur Heart J; 1990 Aug; 11 Suppl E():184-9. PubMed ID: 2146124 [TBL] [Abstract][Full Text] [Related]
23. Stimulatory effect of lipoprotein (a) on proliferation of human mesangial cells: role of lipoprotein (a) in renal disease. Morishita R; Yamamoto K; Yamada S; Matsushita H; Tomita N; Sakurabayashi I; Kaneda Y; Moriguchi A; Higaki J; Ogihara T Biochem Biophys Res Commun; 1998 Aug; 249(2):313-20. PubMed ID: 9712693 [TBL] [Abstract][Full Text] [Related]
24. Expression of adhesion molecules by lp(a): a potential novel mechanism for its atherogenicity. Allen S; Khan S; Tam Sp; Koschinsky M; Taylor P; Yacoub M FASEB J; 1998 Dec; 12(15):1765-76. PubMed ID: 9837867 [TBL] [Abstract][Full Text] [Related]
25. Lipoprotein(a) promotes smooth muscle cell proliferation and dedifferentiation in atherosclerotic lesions of human apo(a) transgenic rabbits. Ichikawa T; Unoki H; Sun H; Shimoyamada H; Marcovina S; Shikama H; Watanabe T; Fan J Am J Pathol; 2002 Jan; 160(1):227-36. PubMed ID: 11786416 [TBL] [Abstract][Full Text] [Related]
26. In vitro inhibition of fibrinolysis by apolipoprotein(a) and lipoprotein(a) is size- and concentration-dependent. Knapp JP; Herrmann W Clin Chem Lab Med; 2004; 42(9):1013-9. PubMed ID: 15497466 [TBL] [Abstract][Full Text] [Related]
27. Oxidized lipoprotein (a) induces cell adhesion molecule Mac-1 (CD 11b) and enhances adhesion of the monocytic cell line U937 to cultured endothelial cells. Ragab MS; Selvaraj P; Sgoutas DS Atherosclerosis; 1996 Jun; 123(1-2):103-13. PubMed ID: 8782841 [TBL] [Abstract][Full Text] [Related]
28. Factors influencing the accumulation in fibrous plaques of lipid derived from low density lipoprotein. II. Preferential immobilization of lipoprotein (a) (Lp(a)). Smith EB; Cochran S Atherosclerosis; 1990 Oct; 84(2-3):173-81. PubMed ID: 2149268 [TBL] [Abstract][Full Text] [Related]
29. Very low density and low density lipoproteins induce nitric oxide synthesis in macrophages. Mohan PF; Desaiah D Biochem Biophys Res Commun; 1994 Nov; 204(3):1047-54. PubMed ID: 7980576 [TBL] [Abstract][Full Text] [Related]
36. Granulocyte macrophage colony-stimulating factor plays a priming role in murine macrophage growth induced by oxidized low density lipoprotein. Miyazaki A; Biwa T; Hakamata H; Sakai M; Sakamoto Y; Maung KK; Yuksel M; Horiuchi S Ann N Y Acad Sci; 2000 May; 902():342-6. PubMed ID: 10865860 [No Abstract] [Full Text] [Related]
37. Stimulatory effects of lipoprotein(a) and low-density lipoprotein on human umbilical vein endothelial cell migration and proliferation are partially mediated by fibroblast growth factor-2. Yano Y; Seishima M; Tokoro Y; Noma A Biochim Biophys Acta; 1998 Jul; 1393(1):26-34. PubMed ID: 9714718 [TBL] [Abstract][Full Text] [Related]
38. Increased expression of u-PA and u-PAR on monocytes by LDL and Lp(a) lipoproteins--consequences for plasmin generation and monocyte adhesion. Ganné F; Vasse M; Beaudeux JL; Peynet J; François A; Paysant J; Lenormand B; Collet JP; Vannier JP; Soria J; Soria C Thromb Haemost; 1999 Apr; 81(4):594-600. PubMed ID: 10235446 [TBL] [Abstract][Full Text] [Related]
39. Interaction of various lipoproteins from normal and dyslipoproteinemic plasma with mouse peritoneal macrophages. Rotheneder M; Krempler F; Kostner GM Ann Biol Clin (Paris); 1988; 46(1):30-4. PubMed ID: 3389575 [TBL] [Abstract][Full Text] [Related]
40. Activation of rat alveolar macrophage-derived latent transforming growth factor beta-1 by plasmin requires interaction with thrombospondin-1 and its cell surface receptor, CD36. Yehualaeshet T; O'Connor R; Green-Johnson J; Mai S; Silverstein R; Murphy-Ullrich JE; Khalil N Am J Pathol; 1999 Sep; 155(3):841-51. PubMed ID: 10487979 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]